首页 > 最新文献

Clinical nutrition最新文献

英文 中文
Impacts of an antioxidant-rich diet and lifestyle factors on gut microbiota diversity and brain health: An exploratory analysis from the NutBrain study 富含抗氧化剂的饮食和生活方式因素对肠道微生物群多样性和大脑健康的影响:来自NutBrain研究的探索性分析。
IF 7.4 2区 医学 Q1 NUTRITION & DIETETICS Pub Date : 2026-03-01 Epub Date: 2026-02-02 DOI: 10.1016/j.clnu.2026.106585
Federica Prinelli , Alfonso Mastropietro , Sara Bernini , Tania Camboni , Clarissa Consolandi , Silvia Conti , Alfredo Costa , Matteo Cotta Ramusino , Nithiya Jesuthasan , Orietta Pansarasa , Elena Perdixi , Anna Pichiecchio , Giovanna Rizzo , Eveljn Scarian , Marco Severgnini , the NutBrain Study Working Group

Background and aims

Healthy diet and lifestyle have been linked to improved gut microbiota diversity and neurocognitive outcomes. However, few human studies have simultaneously examined an antioxidant-rich diet (ARD) in combination with other lifestyle factors and their effects on gut microbiota diversity, brain morphometry, and cognitive function. Our aim was to investigate how the dietary antioxidant capacity and a healthy lifestyle profile influence gut microbiota diversity and composition, brain morphometry, and global cognitive function in older adults.

Methods

In a cross-sectional analysis of the NutBrain study (2019–2023), a cohort of 246 dementia-free individuals aged ≥65 years, completed a 3-day food diary to estimate the total dietary antioxidant capacity (Oxygen Radical Absorbance Capacity - ORAC). Global cognitive function was assessed using the Mini-Mental State Examination (MMSE). Gut microbiota α- and β-diversities and taxa abundances were derived by 16S rRNA amplicon-based sequencing of stool samples. Brain morphometry - including total brain, white matter, grey matter, and ventricular cerebrospinal fluid volumes - was assessed using magnetic resonance imaging. Multiple linear regression models, accounting for many potential confounders (i.e.: socio-demographics, use of drugs, energy intake, inflammatory and anthropometric markers, and APOE genotyping) examined how ORAC, both alone and combined with smoking and physical activity (devising a healthy lifestyle score, Hscore), affected microbiota diversity, MMSE scores, and brain volumes.

Results

Higher ORAC adherence was associated with greater gut microbiota diversity (p ≤ 0.05). Several taxa, such as Barnesiella, Coprococcus, Ruminococcus, Parabacteroides, Lachnospiraceae NK4A136 group, and Clostridia UCG-014 group exhibited increased abundances within the highest ORAC and Hscore tertiles, as compared to the lowest ones. The highest tertile of total ORAC was also positively and significantly associated with greater total brain, white matter, and grey matter volumes (p ≤ 0.05). These associations were stronger in participants classified as having a favourable lifestyle profile (regular physical activity, non-smokers), with notable correlations observed for total brain volume, gut α-diversity, white matter volume and MMSE (p ≤ 0.05).

Conclusions

ARD is associated with increased gut microbiota diversity and enrichment of specific taxa, better cognitive function and brain morphometry outcomes. These associations were stronger in individuals with a healthy lifestyle profile.

Clinical Trial Registry number and website where it was obtained

NCT04461951, https://clinicaltrials.gov/.
背景和目的:健康的饮食和生活方式与改善肠道微生物群多样性和神经认知结果有关。然而,很少有人类研究同时考察富含抗氧化剂的饮食(ARD)与其他生活方式因素的结合及其对肠道微生物群多样性、大脑形态计量学和认知功能的影响。我们的目的是研究膳食抗氧化能力和健康的生活方式如何影响老年人肠道微生物群的多样性和组成、大脑形态和整体认知功能。方法:在对NutBrain研究(2019-2023)的横断分析中,246名年龄≥65岁的无痴呆个体进行队列研究,完成了为期3天的食物日记,以估计总膳食抗氧化能力(氧自由基吸收能力- ORAC)。使用迷你精神状态检查(MMSE)评估整体认知功能。通过粪便样本的16S rRNA扩增子测序,获得肠道微生物群α-和β-多样性和类群丰度。脑形态测定——包括脑总量、脑白质、脑灰质和脑脊液体积——使用磁共振成像进行评估。考虑到许多潜在混杂因素(即:社会人口统计学、药物使用、能量摄入、炎症和人体测量标志物以及APOE基因分型)的多元线性回归模型检验了ORAC单独或与吸烟和体育活动(设计健康生活方式评分,Hscore)联合如何影响微生物群多样性、MMSE评分和脑容量。结果:ORAC依从性越高,肠道菌群多样性越高(p≤0.05)。Barnesiella、Coprococcus、Ruminococcus、Parabacteroides、Lachnospiraceae NK4A136组和Clostridia UCG-014组在ORAC和Hscore最高的分类层内的丰度均高于最低分类层。总ORAC的最高分位数也与较大的脑、白质和灰质总体积呈正相关(p≤0.05)。这些关联在生活方式良好的参与者(有规律的体育锻炼,不吸烟)中更强,在总脑容量、肠道α-多样性、白质体积和MMSE方面观察到显著相关性(p≤0.05)。结论:ARD与肠道微生物群多样性增加、特定分类群丰富、认知功能和脑形态测量结果改善有关。这些关联在拥有健康生活方式的个体中更为明显。临床试验注册号及获取网站:NCT04461951, https://clinicaltrials.gov/。
{"title":"Impacts of an antioxidant-rich diet and lifestyle factors on gut microbiota diversity and brain health: An exploratory analysis from the NutBrain study","authors":"Federica Prinelli ,&nbsp;Alfonso Mastropietro ,&nbsp;Sara Bernini ,&nbsp;Tania Camboni ,&nbsp;Clarissa Consolandi ,&nbsp;Silvia Conti ,&nbsp;Alfredo Costa ,&nbsp;Matteo Cotta Ramusino ,&nbsp;Nithiya Jesuthasan ,&nbsp;Orietta Pansarasa ,&nbsp;Elena Perdixi ,&nbsp;Anna Pichiecchio ,&nbsp;Giovanna Rizzo ,&nbsp;Eveljn Scarian ,&nbsp;Marco Severgnini ,&nbsp;the NutBrain Study Working Group","doi":"10.1016/j.clnu.2026.106585","DOIUrl":"10.1016/j.clnu.2026.106585","url":null,"abstract":"<div><h3>Background and aims</h3><div>Healthy diet and lifestyle have been linked to improved gut microbiota diversity and neurocognitive outcomes. However, few human studies have simultaneously examined an antioxidant-rich diet (ARD) in combination with other lifestyle factors and their effects on gut microbiota diversity, brain morphometry, and cognitive function. Our aim was to investigate how the dietary antioxidant capacity and a healthy lifestyle profile influence gut microbiota diversity and composition, brain morphometry, and global cognitive function in older adults.</div></div><div><h3>Methods</h3><div>In a cross-sectional analysis of the NutBrain study (2019–2023), a cohort of 246 dementia-free individuals aged ≥65 years, completed a 3-day food diary to estimate the total dietary antioxidant capacity (Oxygen Radical Absorbance Capacity - ORAC). Global cognitive function was assessed using the Mini-Mental State Examination (MMSE). Gut microbiota α- and β-diversities and taxa abundances were derived by 16S rRNA amplicon-based sequencing of stool samples. Brain morphometry - including total brain, white matter, grey matter, and ventricular cerebrospinal fluid volumes - was assessed using magnetic resonance imaging. Multiple linear regression models, accounting for many potential confounders (i.e.: socio-demographics, use of drugs, energy intake, inflammatory and anthropometric markers, and APOE genotyping) examined how ORAC, both alone and combined with smoking and physical activity (devising a healthy lifestyle score, Hscore), affected microbiota diversity, MMSE scores, and brain volumes.</div></div><div><h3>Results</h3><div>Higher ORAC adherence was associated with greater gut microbiota diversity (p ≤ 0.05). Several taxa, such as <em>Barnesiella</em>, <em>Coprococcus</em>, <em>Ruminococcus</em>, <em>Parabacteroides</em>, <em>Lachnospiraceae</em> NK4A136 group, and <em>Clostridia</em> UCG-014 group exhibited increased abundances within the highest ORAC and Hscore tertiles, as compared to the lowest ones. The highest tertile of total ORAC was also positively and significantly associated with greater total brain, white matter, and grey matter volumes (p ≤ 0.05). These associations were stronger in participants classified as having a favourable lifestyle profile (regular physical activity, non-smokers), with notable correlations observed for total brain volume, gut α-diversity, white matter volume and MMSE (p ≤ 0.05).</div></div><div><h3>Conclusions</h3><div>ARD is associated with increased gut microbiota diversity and enrichment of specific taxa, better cognitive function and brain morphometry outcomes. These associations were stronger in individuals with a healthy lifestyle profile.</div></div><div><h3>Clinical Trial Registry number and website where it was obtained</h3><div>NCT04461951, <span><span>https://clinicaltrials.gov/</span><svg><path></path></svg></span>.</div></div>","PeriodicalId":10517,"journal":{"name":"Clinical nutrition","volume":"58 ","pages":"Article 106585"},"PeriodicalIF":7.4,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146156299","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bariatric surgery improves fibrinolysis in individuals with obesity with and without concomitant type 2 diabetes 减肥手术可改善伴有或不伴有2型糖尿病的肥胖患者的纤维蛋白溶解。
IF 7.4 2区 医学 Q1 NUTRITION & DIETETICS Pub Date : 2026-03-01 Epub Date: 2026-01-23 DOI: 10.1016/j.clnu.2026.106584
Maja Andersson , Anders Thorell , Peter Henriksson , Anders Kallner , Håkan Wallén , Tomas L. Lindahl , Anna Ågren

Background & aims

Hypofibrinolysis is prevalent in obesity and type 2 diabetes mellitus (T2D) and may be involved in their pathophysiology. Metabolic bariatric surgery (MBS) markedly improves both obesity and T2D, but whether these improvements are related to fibrinolysis is not known. In this study, biomarkers of fibrinolysis were assessed before and after MBS in patients with and without T2D.

Methods

A single center prospective cohort study with 2-year follow-up. The participants were adults with obesity with (n = 28) or without T2D (n = 33) undergoing MBS preceded by 2 weeks of a low-calorie diet (LCD). The plasma concentrations of plasminogen activator inhibitor 1 activity (PAI-1act), tissue plasminogen activator activity (tPAact) and antigen (tPAag), plasmin-antiplasmin complexes (PAP) and fibrinogen were determined at baseline, after LCD and at 6 weeks, 1 and 2 years after MBS.

Results

After LCD and prior to MBS, PAI-1act decreased and PAP increased significantly. Two years after MBS, PAI-1act decreased from baseline 29.8 (63) to 3.8 (121) while tPAact increased (0.08 (390) to 0.23 (150) IU), and PAP increased (544 (54) to 814 (60) ng/mL). tPAag and fibrinogen decreased (16.4 (29) to 9.7 (51) ng/mL and 4.15 (23) to 3.82 (20) g/L, respectively); p < 0.001 for all; (geometric means, except tPAact which is arithmetic mean, coefficient of variation (%CV)). There were no differences in fibrinolysis between groups at baseline or after surgery. Multivariate analysis showed that reduction in body weight and fat mass had the most important influence on fibrinolysis.

Conclusion

Fibrinolysis is significantly improved two years after MBS, as also indicated earlier after the two-week LCD. The lack of differences between patients with vs. without T2D suggests that fat mass reduction rather than improvement of glucose control is most important for improved fibrinolysis after MBS. In summary, our results support hypofibrinolysis as a mechanism in the pathophysiology in obesity.
背景与目的:低纤溶在肥胖和2型糖尿病(T2D)中普遍存在,并可能参与其病理生理。代谢减肥手术(MBS)可显著改善肥胖和T2D,但这些改善是否与纤溶有关尚不清楚。在这项研究中,对伴有和不伴有T2D的患者在MBS前后的纤维蛋白溶解生物标志物进行了评估。方法:单中心前瞻性队列研究,随访2年。参与者是肥胖的成年人(n = 28)或没有T2D的成年人(n = 33),他们在进行MBS之前进行了2周的低热量饮食(LCD)。分别在基线、LCD后、MBS后6周、1年和2年测定血浆纤溶酶原激活物抑制剂1 (PAI-1act)、组织纤溶酶原激活物活性(tPAact)和抗原(tPAag)、纤溶酶抗纤溶酶复合物(PAP)和纤维蛋白原浓度。结果:LCD后和MBS前,PAI-1act明显降低,PAP明显升高。MBS后2年,PAI-1act从基线29.8(63)降至3.8 (121),tPAact增加(0.08(390)至0.23 (150)IU), PAP增加(544(54)至814 (60)ng/mL)。tPAag和纤维蛋白原降低(分别为16.4 (29)~ 9.7 (51)ng/mL和4.15 (23)~ 3.82 (20)g/L);P < 0.001;(几何平均值,除算术平均值tPAact外,变异系数(%CV))。在基线和手术后,两组间的纤溶无差异。多因素分析表明,体重和脂肪量的减少对纤维蛋白溶解有最重要的影响。结论:MBS术后2年纤维蛋白溶解明显改善,两周LCD术后亦有明显改善。T2D患者与非T2D患者之间没有差异,这表明减少脂肪质量而不是改善血糖控制对MBS后改善纤维蛋白溶解最重要。总之,我们的研究结果支持低纤溶是肥胖病理生理的一种机制。
{"title":"Bariatric surgery improves fibrinolysis in individuals with obesity with and without concomitant type 2 diabetes","authors":"Maja Andersson ,&nbsp;Anders Thorell ,&nbsp;Peter Henriksson ,&nbsp;Anders Kallner ,&nbsp;Håkan Wallén ,&nbsp;Tomas L. Lindahl ,&nbsp;Anna Ågren","doi":"10.1016/j.clnu.2026.106584","DOIUrl":"10.1016/j.clnu.2026.106584","url":null,"abstract":"<div><h3>Background &amp; aims</h3><div>Hypofibrinolysis is prevalent in obesity and type 2 diabetes mellitus (T2D) and may be involved in their pathophysiology. Metabolic bariatric surgery (MBS) markedly improves both obesity and T2D, but whether these improvements are related to fibrinolysis is not known. In this study, biomarkers of fibrinolysis were assessed before and after MBS in patients with and without T2D.</div></div><div><h3>Methods</h3><div>A single center prospective cohort study with 2-year follow-up. The participants were adults with obesity with (n = 28) or without T2D (n = 33) undergoing MBS preceded by 2 weeks of a low-calorie diet (LCD). The plasma concentrations of plasminogen activator inhibitor 1 activity (PAI-1<sub>act</sub>), tissue plasminogen activator <em>activity</em> (tPA<sub>act</sub>) and <em>antigen</em> (tPA<sub>ag</sub>), plasmin-antiplasmin complexes (PAP) and fibrinogen were determined at baseline, after LCD and at 6 weeks, 1 and 2 years after MBS.</div></div><div><h3>Results</h3><div>After LCD and prior to MBS, PAI-1<sub>act</sub> decreased and PAP increased significantly. Two years after MBS, PAI-1<sub>act</sub> decreased from baseline 29.8 (63) to 3.8 (121) while tPA<sub>act</sub> increased (0.08 (390) to 0.23 (150) IU), and PAP increased (544 (54) to 814 (60) ng/mL). tPA<sub>ag</sub> and fibrinogen decreased (16.4 (29) to 9.7 (51) ng/mL and 4.15 (23) to 3.82 (20) g/L, respectively); p &lt; 0.001 for all; (geometric means, except tPA<sub>act</sub> which is arithmetic mean, coefficient of variation (%CV)). There were no differences in fibrinolysis between groups at baseline or after surgery. Multivariate analysis showed that reduction in body weight and fat mass had the most important influence on fibrinolysis.</div></div><div><h3>Conclusion</h3><div>Fibrinolysis is significantly improved two years after MBS, as also indicated earlier after the two-week LCD. The lack of differences between patients with vs. without T2D suggests that fat mass reduction rather than improvement of glucose control is most important for improved fibrinolysis after MBS. In summary, our results support hypofibrinolysis as a mechanism in the pathophysiology in obesity.</div></div>","PeriodicalId":10517,"journal":{"name":"Clinical nutrition","volume":"58 ","pages":"Article 106584"},"PeriodicalIF":7.4,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146104144","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dietary flavonoid intake and psychological well-being – A bidirectional relationship 膳食类黄酮摄入量与心理健康-双向关系
IF 7.4 2区 医学 Q1 NUTRITION & DIETETICS Pub Date : 2026-03-01 Epub Date: 2026-01-19 DOI: 10.1016/j.clnu.2026.106579
Alysha S. Thompson , Nicola P. Bondonno , Yan Lydia Liu , Farah Qureshi , Laura D. Kubzansky , Claudia Trudel-Fitzgerald , Julia K. Boehm , Eric B. Rimm , Aedín Cassidy

Background and aim

Higher dietary flavonoid intake has been associated with lower risks of mortality and major chronic disease, yet its relationship with psychological well-being (PWB), a key contributor to health and quality of life, remains unclear. This study aimed to investigate bidirectional associations between dietary flavonoid intake and two PWB facets: happiness (positive emotional state) and optimism (generalized expectation of positive outcomes). Specifically, we examined whether (1) overall flavonoid-rich dietary patterns (flavodiet score), (2) intake of specific flavonoid-rich foods, and (3) total flavonoid and subclass intakes were each associated with happiness and optimism over time.

Methods

Data were drawn from the Nurses’ Health Study to form two analytical samples. Flavonoid intake measured in 1990 (n = 44,659) was examined in relation to sustained happiness (1992–2000) while intake in 2002 (n = 36,723) was analysed in relation to sustained optimism (2004–2012). Secondary analyses assessed whether higher baseline levels of each PWB facet were associated with sustained higher flavonoid intake, over up to 18 years. Associations were assessed using generalized estimating equations, adjusting for potential confounders.

Results

Higher flavodiet scores were associated with a 3–6 % higher likelihood of sustained happiness [RRQ4vsQ1 (95 % CI): 1.03 (1.02–1.05)] and optimism [RRQ4vsQ1 (95 % CI): 1.06 (1.01–1.11)]. Specific flavonoid-rich foods (strawberries, apples, oranges, grapefruit, blueberries) were associated with a 3–16 % greater likelihood of sustained PWB, across the two facets. Similarly, total flavonoid and subclass intakes were associated with a 2–18 % greater likelihood of sustained PWB. Women with higher baseline levels of happiness or optimism were also more likely to sustain a higher flavonoid intake.

Conclusions

Consuming ∼3 servings/day of flavonoid-rich foods is associated with sustained PWB, and higher baseline PWB is associated with sustained higher flavonoid intake over up to 18 years. This bidirectional relationship suggests that integrated interventions targeting both diet and well-being may help promote long-term health and reduce chronic disease risk.
背景和目的较高的膳食类黄酮摄入量与较低的死亡率和主要慢性疾病风险相关,但其与心理健康(PWB)的关系尚不清楚,PWB是健康和生活质量的关键因素。本研究旨在探讨膳食类黄酮摄入量与幸福(积极情绪状态)和乐观(积极结果的普遍期望)两个PWB方面的双向关系。具体来说,我们研究了(1)总体富含类黄酮的饮食模式(flavodiet评分),(2)摄入特定富含类黄酮的食物,以及(3)摄入总类黄酮和亚类黄酮是否与长期的快乐和乐观有关。方法从护士健康调查中抽取数据,形成两个分析样本。1990年的类黄酮摄入量(n = 44,659)与持续幸福(1992-2000)的关系进行了研究,2002年的摄入量(n = 36,723)与持续乐观(2004-2012)的关系进行了分析。二次分析评估了在长达18年的时间里,较高的PWB各方面基线水平是否与持续较高的类黄酮摄入量有关。使用广义估计方程评估关联,调整潜在混杂因素。结果高脂肪饮食评分与高3 - 6%的持续快乐的可能性相关[RRQ4vsQ1 (95% CI): 1.03(1.02-1.05)]和乐观[RRQ4vsQ1 (95% CI): 1.06(1.01-1.11)]。特定的富含类黄酮的食物(草莓、苹果、橙子、葡萄柚、蓝莓)在这两个方面与持续PWB的可能性增加3 - 16%有关。同样,总黄酮和亚类摄入量与持续PWB的可能性增加2 - 18%相关。幸福或乐观基线水平较高的女性也更有可能维持较高的类黄酮摄入量。结论:每天食用~ 3份富含类黄酮的食物与持续的PWB有关,较高的基线PWB与长达18年的持续较高的类黄酮摄入量有关。这种双向关系表明,以饮食和健康为目标的综合干预措施可能有助于促进长期健康并降低慢性病风险。
{"title":"Dietary flavonoid intake and psychological well-being – A bidirectional relationship","authors":"Alysha S. Thompson ,&nbsp;Nicola P. Bondonno ,&nbsp;Yan Lydia Liu ,&nbsp;Farah Qureshi ,&nbsp;Laura D. Kubzansky ,&nbsp;Claudia Trudel-Fitzgerald ,&nbsp;Julia K. Boehm ,&nbsp;Eric B. Rimm ,&nbsp;Aedín Cassidy","doi":"10.1016/j.clnu.2026.106579","DOIUrl":"10.1016/j.clnu.2026.106579","url":null,"abstract":"<div><h3>Background and aim</h3><div>Higher dietary flavonoid intake has been associated with lower risks of mortality and major chronic disease, yet its relationship with psychological well-being (PWB), a key contributor to health and quality of life, remains unclear. This study aimed to investigate bidirectional associations between dietary flavonoid intake and two PWB facets: happiness (positive emotional state) and optimism (generalized expectation of positive outcomes). Specifically, we examined whether (1) overall flavonoid-rich dietary patterns (flavodiet score), (2) intake of specific flavonoid-rich foods, and (3) total flavonoid and subclass intakes were each associated with happiness and optimism over time.</div></div><div><h3>Methods</h3><div>Data were drawn from the Nurses’ Health Study to form two analytical samples. Flavonoid intake measured in 1990 (n = 44,659) was examined in relation to sustained happiness (1992–2000) while intake in 2002 (n = 36,723) was analysed in relation to sustained optimism (2004–2012). Secondary analyses assessed whether higher baseline levels of each PWB facet were associated with sustained higher flavonoid intake, over up to 18 years. Associations were assessed using generalized estimating equations, adjusting for potential confounders.</div></div><div><h3>Results</h3><div>Higher flavodiet scores were associated with a 3–6 % higher likelihood of sustained happiness [RR<sub>Q4vsQ1</sub> (95 % CI): 1.03 (1.02–1.05)] and optimism [RR<sub>Q4vsQ1</sub> (95 % CI): 1.06 (1.01–1.11)]. Specific flavonoid-rich foods (strawberries, apples, oranges, grapefruit, blueberries) were associated with a 3–16 % greater likelihood of sustained PWB, across the two facets. Similarly, total flavonoid and subclass intakes were associated with a 2–18 % greater likelihood of sustained PWB. Women with higher baseline levels of happiness or optimism were also more likely to sustain a higher flavonoid intake.</div></div><div><h3>Conclusions</h3><div>Consuming ∼3 servings/day of flavonoid-rich foods is associated with sustained PWB, and higher baseline PWB is associated with sustained higher flavonoid intake over up to 18 years. This bidirectional relationship suggests that integrated interventions targeting both diet and well-being may help promote long-term health and reduce chronic disease risk.</div></div>","PeriodicalId":10517,"journal":{"name":"Clinical nutrition","volume":"58 ","pages":"Article 106579"},"PeriodicalIF":7.4,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146077176","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Retraction notice to “A randomized trial of iron- and zinc-biofortified pearl millet-based complementary feeding in children aged 12 to 18 months living in urban slums” [Clin Nutr 41 (2022) 937–947] “城市贫民窟12至18个月儿童铁锌生物强化珍珠米补充喂养的随机试验”[临床医学杂志41(2022)937-947]。
IF 7.4 2区 医学 Q1 NUTRITION & DIETETICS Pub Date : 2026-03-01 Epub Date: 2026-01-21 DOI: 10.1016/j.clnu.2026.106578
Saurabh Mehta , Samantha L. Huey , Padmini S. Ghugre , Ramesh D. Potdar , Sudha Venkatramanan , Jesse T. Krisher , Caleb J. Ruth , Harsha V. Chopra , Aparna Thorat , Varsha Thakker , Lynn Johnson , Laura Powis , Yadurshini Raveendran , Jere D. Haas , Julia L. Finkelstein , Shobha A. Udipi , Project Sabal
This article has been retracted: please see Elsevier policy on article withdrawal (https://www.elsevier.com/about/policies-and-standards/article-withdrawal). This article is retracted at the request of the authors. During post-publication data re-analyses, the authors found four additional hemoglobin datapoints at the endpoint of the trial reported in the above-named article that move the p-value for the primary outcome - the impact of intervention on the change in hemoglobin concentrations across the duration of the trial - from 0.053 to 0.044. Furthermore, the WHO has recently released a revised set of cutoffs for anemia [WHO 2024], and the anemia cutoff for the age group of interest in this article, 12–23 months, was lowered from a hemoglobin concentration of 11 g/dL to 10.5 g/dL. As such, the authors wish to report these revised estimates of anemia based on the revised WHO cutoffs to keep the findings as updated as possible and useful for guidelines. The Editors considered this request and agreed to the retraction of the article. The authors were invited to submit a revised version of the article, which has been peer-reviewed and accepted for publication in the journal. This retraction notice will be updated with a link to the revised paper when it is published.
本文已被撤回:请参阅Elsevier文章撤回政策(https://www.elsevier.com/about/policies-and-standards/article-withdrawal)。应作者的要求,这篇文章被撤回了。在发表后的数据重新分析中,作者在上述文章中报道的试验终点发现了四个额外的血红蛋白数据点,这些数据点将主要结局(干预对试验期间血红蛋白浓度变化的影响)的p值从0.053移动到0.044。此外,世卫组织最近发布了一套修订后的贫血临界值[WHO 2024],本文关注的年龄组(12-23个月)的贫血临界值从血红蛋白浓度11克/分升降至10.5克/分升。因此,作者希望根据修订后的世卫组织临界值报告这些修订后的贫血估计,以使研究结果尽可能更新并对指南有用。编辑们考虑了这个请求,同意撤回这篇文章。作者被邀请提交一份经过同行评审的修订版文章,并被接受在期刊上发表。本撤稿通知将在论文发表后更新并附上修改后论文的链接。
{"title":"Retraction notice to “A randomized trial of iron- and zinc-biofortified pearl millet-based complementary feeding in children aged 12 to 18 months living in urban slums” [Clin Nutr 41 (2022) 937–947]","authors":"Saurabh Mehta ,&nbsp;Samantha L. Huey ,&nbsp;Padmini S. Ghugre ,&nbsp;Ramesh D. Potdar ,&nbsp;Sudha Venkatramanan ,&nbsp;Jesse T. Krisher ,&nbsp;Caleb J. Ruth ,&nbsp;Harsha V. Chopra ,&nbsp;Aparna Thorat ,&nbsp;Varsha Thakker ,&nbsp;Lynn Johnson ,&nbsp;Laura Powis ,&nbsp;Yadurshini Raveendran ,&nbsp;Jere D. Haas ,&nbsp;Julia L. Finkelstein ,&nbsp;Shobha A. Udipi ,&nbsp;Project Sabal","doi":"10.1016/j.clnu.2026.106578","DOIUrl":"10.1016/j.clnu.2026.106578","url":null,"abstract":"<div><div>This article has been retracted: please see Elsevier policy on article withdrawal (<span><span>https://www.elsevier.com/about/policies-and-standards/article-withdrawal</span><svg><path></path></svg></span>). This article is retracted at the request of the authors. During post-publication data re-analyses, the authors found four additional hemoglobin datapoints at the endpoint of the trial reported in the above-named article that move the p-value for the primary outcome - the impact of intervention on the change in hemoglobin concentrations across the duration of the trial - from 0.053 to 0.044. Furthermore, the WHO has recently released a revised set of cutoffs for anemia [WHO 2024], and the anemia cutoff for the age group of interest in this article, 12–23 months, was lowered from a hemoglobin concentration of 11 g/dL to 10.5 g/dL. As such, the authors wish to report these revised estimates of anemia based on the revised WHO cutoffs to keep the findings as updated as possible and useful for guidelines. The Editors considered this request and agreed to the retraction of the article. The authors were invited to submit a revised version of the article, which has been peer-reviewed and accepted for publication in the journal. This retraction notice will be updated with a link to the revised paper when it is published.</div></div>","PeriodicalId":10517,"journal":{"name":"Clinical nutrition","volume":"58 ","pages":"Article 106578"},"PeriodicalIF":7.4,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146028378","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Proof of concept for an age- and inflammation-adjusted model for the establishment of pediatric serum copper reference intervals 建立儿童血清铜参考区间的年龄和炎症调整模型的概念证明。
IF 7.4 2区 医学 Q1 NUTRITION & DIETETICS Pub Date : 2026-03-01 Epub Date: 2026-01-25 DOI: 10.1016/j.clnu.2026.106586
Helena Rodriguez-Gonzalez , Angela Arias , Elisabet Poyatos , Mariela Mercedes de los Santos , Beatriz Minguez , Silvia Meavilla , Camila Garcia-Volpe , Ines Loverdos , Cristina Molera , Mercedes Casado , Aida Ormazabal , Alexandre Perera-Lluna , Rafael Artuch

Background & aims:

Copper is a trace element essential for enzymatic reactions, but excessive accumulation can cause toxicity. Accurate interpretation of serum copper concentrations is crucial for diagnosing conditions such as Wilson's disease, liver dysfunction, and nutritional deficiencies. Current reference intervals often ignore the effect of inflammation and are typically established using discrete age groups rather than modelling age as a continuous variable. This study aimed to establish continuous, age-adjusted reference intervals for serum copper and to develop a method for correcting inflammation-related variability.

Methods

We retrospectively analyzed serum copper concentrations in a pediatric cohort of 4,368 unique samples. Inflammatory status was assessed using erythrocyte sedimentation rate (ESR), fibrinogen, and C-reactive protein (CRP). Samples without inflammation were used to generate age-continuous reference intervals through polynomial regression. To quantify and adjust for inflammation effects, we developed a composite inflammation score using partial least squares regression on standardized values of the three acute-phase markers and applied it to correct copper concentrations in samples exhibiting inflammation.

Results

Serum copper showed a nonlinear relationship with age. Inflammation elevated copper concentrations by approximately 24 %. The composite inflammation score independently predicted this variability in copper concentrations, and adjustment using the score restored copper concentrations within reference limits, reducing the risk of data misinterpretation.

Conclusion

Our findings underscore the necessity of considering both age and inflammation variables when interpreting pediatric serum copper concentrations. We provide continuous, age-adjusted reference intervals and a method to correct for inflammation-related variability, enhancing data interpretation. We propose a proof-of-concept potentially applicable to other biomarkers related with metabolic and nutritional disturbances in chronic and acute diseases.
背景与目的:铜是酶促反应必需的微量元素,但过量积累会引起毒性。准确解释血清铜浓度对于诊断威尔森氏病、肝功能障碍和营养缺乏等疾病至关重要。目前的参考区间往往忽略了炎症的影响,并且通常使用离散年龄组建立,而不是将年龄建模为连续变量。本研究旨在建立连续的、年龄调整的血清铜参考区间,并开发一种纠正炎症相关变异性的方法。方法:我们回顾性分析了4,368个独特样本的儿科队列的血清铜浓度。使用红细胞沉降率(ESR)、纤维蛋白原和c反应蛋白(CRP)评估炎症状态。无炎症的样本通过多项式回归生成年龄连续参考区间。为了量化和调整炎症效应,我们对三种急性期标志物的标准化值使用偏最小二乘回归开发了一种复合炎症评分,并将其应用于校正炎症样品中的铜浓度。结果:血清铜与年龄呈非线性关系。炎症使铜浓度升高约24%。复合炎症评分独立预测了铜浓度的变异性,使用该评分进行调整后,铜浓度恢复在参考范围内,降低了数据误解的风险。结论:我们的研究结果强调了在解释儿童血清铜浓度时考虑年龄和炎症变量的必要性。我们提供了连续的、年龄调整的参考区间和一种方法来纠正炎症相关的变异性,增强了数据的解释。我们提出了一种潜在适用于慢性和急性疾病中与代谢和营养紊乱相关的其他生物标志物的概念验证。
{"title":"Proof of concept for an age- and inflammation-adjusted model for the establishment of pediatric serum copper reference intervals","authors":"Helena Rodriguez-Gonzalez ,&nbsp;Angela Arias ,&nbsp;Elisabet Poyatos ,&nbsp;Mariela Mercedes de los Santos ,&nbsp;Beatriz Minguez ,&nbsp;Silvia Meavilla ,&nbsp;Camila Garcia-Volpe ,&nbsp;Ines Loverdos ,&nbsp;Cristina Molera ,&nbsp;Mercedes Casado ,&nbsp;Aida Ormazabal ,&nbsp;Alexandre Perera-Lluna ,&nbsp;Rafael Artuch","doi":"10.1016/j.clnu.2026.106586","DOIUrl":"10.1016/j.clnu.2026.106586","url":null,"abstract":"<div><h3>Background &amp; aims:</h3><div>Copper is a trace element essential for enzymatic reactions, but excessive accumulation can cause toxicity. Accurate interpretation of serum copper concentrations is crucial for diagnosing conditions such as Wilson's disease, liver dysfunction, and nutritional deficiencies. Current reference intervals often ignore the effect of inflammation and are typically established using discrete age groups rather than modelling age as a continuous variable. This study aimed to establish continuous, age-adjusted reference intervals for serum copper and to develop a method for correcting inflammation-related variability.</div></div><div><h3>Methods</h3><div>We retrospectively analyzed serum copper concentrations in a pediatric cohort of 4,368 unique samples. Inflammatory status was assessed using erythrocyte sedimentation rate (ESR), fibrinogen, and C-reactive protein (CRP). Samples without inflammation were used to generate age-continuous reference intervals through polynomial regression. To quantify and adjust for inflammation effects, we developed a composite inflammation score using partial least squares regression on standardized values of the three acute-phase markers and applied it to correct copper concentrations in samples exhibiting inflammation.</div></div><div><h3>Results</h3><div>Serum copper showed a nonlinear relationship with age. Inflammation elevated copper concentrations by approximately 24 %. The composite inflammation score independently predicted this variability in copper concentrations, and adjustment using the score restored copper concentrations within reference limits, reducing the risk of data misinterpretation.</div></div><div><h3>Conclusion</h3><div>Our findings underscore the necessity of considering both age and inflammation variables when interpreting pediatric serum copper concentrations. We provide continuous, age-adjusted reference intervals and a method to correct for inflammation-related variability, enhancing data interpretation. We propose a proof-of-concept potentially applicable to other biomarkers related with metabolic and nutritional disturbances in chronic and acute diseases.</div></div>","PeriodicalId":10517,"journal":{"name":"Clinical nutrition","volume":"58 ","pages":"Article 106586"},"PeriodicalIF":7.4,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146104134","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How low can we go with hypocaloric feeding for critically ill patients? For how long can it be continued? 对危重病人的低热量喂养能达到多低?它能持续多久?
IF 7.4 2区 医学 Q1 NUTRITION & DIETETICS Pub Date : 2026-03-01 Epub Date: 2026-01-29 DOI: 10.1016/j.clnu.2026.106588
Emmanuel Pardo, Ronan Thibault
{"title":"How low can we go with hypocaloric feeding for critically ill patients? For how long can it be continued?","authors":"Emmanuel Pardo,&nbsp;Ronan Thibault","doi":"10.1016/j.clnu.2026.106588","DOIUrl":"10.1016/j.clnu.2026.106588","url":null,"abstract":"","PeriodicalId":10517,"journal":{"name":"Clinical nutrition","volume":"58 ","pages":"Article 106588"},"PeriodicalIF":7.4,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146164551","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Proteins in artificial nutrition: toward an individualized and phase-specific prescription 人工营养中的蛋白质:走向个体化和阶段性处方
IF 7.4 2区 医学 Q1 NUTRITION & DIETETICS Pub Date : 2026-03-01 Epub Date: 2026-01-14 DOI: 10.1016/j.clnu.2026.106577
Philipp Schuetz , Frank Carrera-Gil , Carla Wunderle
Protein is a central component of artificial nutrition, yet its optimal dose and timing remain controversial. Provision of both insufficient and excessive protein is associated with adverse outcomes. Inadequate intake promotes negative nitrogen balance, muscle wasting, impaired tissue healing and repair, and increased risk of infection, whereas excessive protein may exceed metabolic capacity, causing azotemia, hepatic or renal strain, and reduced metabolic flexibility — particularly in patients with renal dysfunction. Emerging evidence indicates that the optimal protein dose is strongly influenced by patient-specific characteristics and evolves throughout the course of illness, supporting an individualized, phase-adapted strategy for protein provision rather than a fixed universal target. During early critical illness, catabolism predominates and high protein doses may not be effectively utilized. In contrast, during recovery and stabilization, higher protein targets appear beneficial for restoring lean body mass and functional capacity. This dynamic trajectory underscores the need to abandon universal recommendations in favor of personalized prescriptions. Although instruments such as nitrogen balance, body composition analysis, and indirect calorimetry can provide information about protein dosage, their routine use in clinical practice is limited and interpretation in acute illnesses remains difficult. Pragmatic, bedside strategies and the phenotyping of patients using biomarkers are, therefore, needed to tailor protein provision according to disease stage, organ function, and anabolic capacity. This opinion paper explores mechanistic insights, evidence from clinical trials, and guidelines on protein supplementation, explores biomarker-driven personalization, and highlights ongoing challenges and future research priorities in nutritional therapy.
蛋白质是人工营养的核心成分,但其最佳剂量和时间仍然存在争议。蛋白质供应不足和过量都与不良后果有关。摄入不足会促进负氮平衡,肌肉萎缩,组织愈合和修复受损,并增加感染风险,而过量的蛋白质可能超过代谢能力,导致氮血症,肝脏或肾脏应变,并降低代谢灵活性-特别是在肾功能不全的患者中。新出现的证据表明,最佳蛋白质剂量受到患者特异性特征的强烈影响,并在整个疾病过程中不断发展,这支持个性化的、适应阶段的蛋白质供应策略,而不是固定的普遍目标。在早期危重疾病期间,分解代谢占主导地位,高蛋白剂量可能无法有效利用。相反,在恢复和稳定期间,较高的蛋白质目标似乎有利于恢复瘦体重和功能能力。这一动态轨迹强调了放弃普遍建议而采用个性化处方的必要性。虽然氮平衡、身体成分分析和间接量热等仪器可以提供蛋白质剂量的信息,但它们在临床实践中的常规应用有限,在急性疾病中的解释仍然困难。因此,需要实用的床边策略和使用生物标志物的患者表型,根据疾病分期、器官功能和合成代谢能力定制蛋白质供应。本文探讨了蛋白质补充的机理见解、临床试验证据和指南,探讨了生物标志物驱动的个性化,并强调了营养治疗中正在面临的挑战和未来的研究重点。
{"title":"Proteins in artificial nutrition: toward an individualized and phase-specific prescription","authors":"Philipp Schuetz ,&nbsp;Frank Carrera-Gil ,&nbsp;Carla Wunderle","doi":"10.1016/j.clnu.2026.106577","DOIUrl":"10.1016/j.clnu.2026.106577","url":null,"abstract":"<div><div>Protein is a central component of artificial nutrition, yet its optimal dose and timing remain controversial. Provision of both insufficient and excessive protein is associated with adverse outcomes. Inadequate intake promotes negative nitrogen balance, muscle wasting, impaired tissue healing and repair, and increased risk of infection, whereas excessive protein may exceed metabolic capacity, causing azotemia, hepatic or renal strain, and reduced metabolic flexibility — particularly in patients with renal dysfunction. Emerging evidence indicates that the optimal protein dose is strongly influenced by patient-specific characteristics and evolves throughout the course of illness, supporting an individualized, phase-adapted strategy for protein provision rather than a fixed universal target. During early critical illness, catabolism predominates and high protein doses may not be effectively utilized. In contrast, during recovery and stabilization, higher protein targets appear beneficial for restoring lean body mass and functional capacity. This dynamic trajectory underscores the need to abandon universal recommendations in favor of personalized prescriptions. Although instruments such as nitrogen balance, body composition analysis, and indirect calorimetry can provide information about protein dosage, their routine use in clinical practice is limited and interpretation in acute illnesses remains difficult. Pragmatic, bedside strategies and the phenotyping of patients using biomarkers are, therefore, needed to tailor protein provision according to disease stage, organ function, and anabolic capacity. This opinion paper explores mechanistic insights, evidence from clinical trials, and guidelines on protein supplementation, explores biomarker-driven personalization, and highlights ongoing challenges and future research priorities in nutritional therapy.</div></div>","PeriodicalId":10517,"journal":{"name":"Clinical nutrition","volume":"58 ","pages":"Article 106577"},"PeriodicalIF":7.4,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146049112","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Teachable moment for lifestyle and dietary changes after a myocardial infarction: Identifying the window of opportunity 心肌梗死后生活方式和饮食改变的教育时刻:确定机会之窗。
IF 7.4 2区 医学 Q1 NUTRITION & DIETETICS Pub Date : 2026-03-01 Epub Date: 2026-01-31 DOI: 10.1016/j.clnu.2026.106589
Bahram Yosofi , Manon Reesink , Susan van Maren , Manon G. van den Berg , Jessica C. Kiefte-de Jong , Robin Nijveldt , Saloua El Messaoudi
Background and aims: While lifestyle changes, including dietary modifications, are crucial for reducing cardiovascular risk, adherence to these changes remains low. A ‘teachable moment’ (TM) can improve adherence, and a myocardial infarction (MI) can serve as a TM for initiating lifestyle and dietary changes. However, the timing and duration of receptiveness remain unclear. This study aimed to investigate whether an MI serves as a TM for lifestyle and dietary change intentions, to explore when this TM is most pronounced and to identify predictors of this TM.

Methods

In this cross-sectional survey study, patients who experienced an MI reported their intentions to change lifestyle and diet, along with the validated CardiacTM scale. Patients were categorised based on the time since MI: within 2 weeks, 6 months, 1 year, and 3 years ago. Intentions to change lifestyle and diet were compared between groups. Logistic regression analyses were performed to examine the association between the CardiacTM factors, time elapsed post–MI and intentions to change lifestyle and diet.

Results

241 patients were included in the analyses. Event-related lifestyle change intentions differed significantly between the 6-month and 1-year post–MI groups (30.6 % vs. 55.4 %, p = 0.003), as well as between the 2-weeks and 6-month post–MI groups (54.3 % and 30.6%p = 0.010). The intention to change dietary behaviour and general lifestyle were comparable across groups. Multivariate logistic regression revealed that time post–MI (p = 0.018), changed self-concept (B = 0.748; p < 0.001) and cardiovascular disease (CVD) group identity (B = 0.550; p = 0.021) were significantly associated with event-related lifestyle change intentions. Affective impact (B = −0.496; p < 0.001), changed self-concept (B = 0.506; p < 0.001), perceived risk of non-communicable diseases (NCD) (B = −0.450; p = 0.003) and anticipated regret (B = 0.345; p = 0.008) were significantly associated with general lifestyle change intentions. Significant predictors of dietary change intentions were affective impact (B = 0.298; p = 0.025) and changed self-concept (B = 0.518; p < 0.001).

Conclusions

A significant association was found between time post–MI and event-related lifestyle change intentions. Changed self-concept was the strongest predictor of TM for dietary, event-related and general lifestyle change intentions. These results suggest lifestyle interventions should be provided shortly after the event and personalised based on patients' perceptions of their MI to maximise effectiveness.
背景和目的:虽然生活方式的改变,包括饮食的调整,对降低心血管风险至关重要,但坚持这些改变的程度仍然很低。“可教时刻”(TM)可以提高依从性,心肌梗死(MI)可以作为开始生活方式和饮食改变的TM。然而,接受的时间和持续时间仍不清楚。本研究旨在调查MI是否可以作为生活方式和饮食改变意图的TM,探索何时这种TM最明显,并确定这种TM的预测因子。方法:在这项横断面调查研究中,经历心肌梗死的患者报告了他们改变生活方式和饮食的意图,并使用了经过验证的CardiacTM量表。根据心肌梗死发生时间对患者进行分类:2周内、6个月内、1年内和3年前。对两组之间改变生活方式和饮食习惯的意愿进行比较。采用Logistic回归分析来检验CardiacTM因素、心肌梗死后的时间和改变生活方式和饮食的意愿之间的关系。结果:241例患者纳入分析。事件相关的生活方式改变意愿在心肌梗死后6个月和1年组之间差异显著(30.6%对55.4%,p = 0.003),以及心肌梗死后2周和6个月组之间(54.3%和30.6%p = 0.010)。改变饮食行为和一般生活方式的意图在各组之间具有可比性。多因素logistic回归显示,心肌梗死后时间(p = 0.018)、自我概念改变(B = 0.748, p < 0.001)和心血管疾病(CVD)群体认同(B = 0.550, p = 0.021)与事件相关的生活方式改变意图显著相关。情感影响(B = -0.496; p < 0.001)、自我概念改变(B = 0.506; p < 0.001)、感知非传染性疾病(NCD)风险(B = -0.450; p = 0.003)和预期后悔(B = 0.345; p = 0.008)与一般生活方式改变意图显著相关。饮食改变意向的显著预测因子为情感影响(B = 0.298; p = 0.025)和自我概念改变(B = 0.518; p < 0.001)。结论:心肌梗死后时间与事件相关的生活方式改变意图之间存在显著关联。改变自我概念是TM对饮食、事件相关和一般生活方式改变意图的最强预测因子。这些结果表明,生活方式干预应在事件发生后不久提供,并根据患者对其心肌梗死的看法进行个性化治疗,以最大限度地提高疗效。
{"title":"Teachable moment for lifestyle and dietary changes after a myocardial infarction: Identifying the window of opportunity","authors":"Bahram Yosofi ,&nbsp;Manon Reesink ,&nbsp;Susan van Maren ,&nbsp;Manon G. van den Berg ,&nbsp;Jessica C. Kiefte-de Jong ,&nbsp;Robin Nijveldt ,&nbsp;Saloua El Messaoudi","doi":"10.1016/j.clnu.2026.106589","DOIUrl":"10.1016/j.clnu.2026.106589","url":null,"abstract":"<div><div><em>Background and aims</em>: While lifestyle changes, including dietary modifications, are crucial for reducing cardiovascular risk, adherence to these changes remains low. A ‘teachable moment’ (TM) can improve adherence, and a myocardial infarction (MI) can serve as a TM for initiating lifestyle and dietary changes. However, the timing and duration of receptiveness remain unclear. This study aimed to investigate whether an MI serves as a TM for lifestyle and dietary change intentions, to explore when this TM is most pronounced and to identify predictors of this TM.</div></div><div><h3>Methods</h3><div>In this cross-sectional survey study, patients who experienced an MI reported their intentions to change lifestyle and diet, along with the validated CardiacTM scale. Patients were categorised based on the time since MI: within 2 weeks, 6 months, 1 year, and 3 years ago. Intentions to change lifestyle and diet were compared between groups. Logistic regression analyses were performed to examine the association between the CardiacTM factors, time elapsed post–MI and intentions to change lifestyle and diet.</div></div><div><h3>Results</h3><div>241 patients were included in the analyses. Event-related lifestyle change intentions differed significantly between the 6-month and 1-year post–MI groups (30.6 % vs. 55.4 %, p = 0.003), as well as between the 2-weeks and 6-month post–MI groups (54.3 % and 30.6%p = 0.010). The intention to change dietary behaviour and general lifestyle were comparable across groups. Multivariate logistic regression revealed that time post–MI (p = 0.018), changed self-concept (B = 0.748; p &lt; 0.001) and cardiovascular disease (CVD) group identity (B = 0.550; p = 0.021) were significantly associated with event-related lifestyle change intentions. Affective impact (B = −0.496; p &lt; 0.001), changed self-concept (B = 0.506; p &lt; 0.001), perceived risk of non-communicable diseases (NCD) (B = −0.450; p = 0.003) and anticipated regret (B = 0.345; p = 0.008) were significantly associated with general lifestyle change intentions. Significant predictors of dietary change intentions were affective impact (B = 0.298; p = 0.025) and changed self-concept (B = 0.518; p &lt; 0.001).</div></div><div><h3>Conclusions</h3><div>A significant association was found between time post–MI and event-related lifestyle change intentions. Changed self-concept was the strongest predictor of TM for dietary, event-related and general lifestyle change intentions. These results suggest lifestyle interventions should be provided shortly after the event and personalised based on patients' perceptions of their MI to maximise effectiveness.</div></div>","PeriodicalId":10517,"journal":{"name":"Clinical nutrition","volume":"58 ","pages":"Article 106589"},"PeriodicalIF":7.4,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146164504","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nutrition care in adults with spinal cord injuries and disorders with pressure injuries: A systematic review of clinical practice guidelines 成人脊髓损伤和压迫性损伤障碍的营养护理:临床实践指南的系统回顾
IF 7.4 2区 医学 Q1 NUTRITION & DIETETICS Pub Date : 2026-03-01 Epub Date: 2026-01-20 DOI: 10.1016/j.clnu.2026.106580
Yiwen Wang , Man Ching Lo , Murray Fisher , Katherine Desneves , Amy Nevin , Priya lyer
Pressure injuries (PIs) are a common and costly complication in adults with spinal cord injuries and disorders (SCI/D), with a global prevalence of 32 % and a lifetime risk exceeding 85 % in Australia. Nutrition is a key factor in the prevention and management of PIs, supporting wound healing, immune function, and overall recovery. This systematic review evaluated the quality, scope, and methodological rigour of 17 international clinical practice guidelines (CPGs) published since 2010 that included nutrition recommendations for PIs in adults with SCI/D. Using the AGREE II and the AGREE-REX tools, this review assessed overall guideline quality and nutrition-specific recommendations mapped to the Nutrition Care Process domains. Seven CPGs were rated high quality with AGREE II, and three with AGREE-REX. While most guidelines focussed on nutrition interventions, limited detail was provided on assessment and monitoring. Considerable variation was found in the rigour and specificity of recommendations. These findings underscore a need for high-quality, SCI/D-specific guidelines that offer consistent, evidence-based, actionable nutrition guidance, particularly in the under-represented areas of assessment and monitoring, to better support PI prevention and treatment in this vulnerable population.
压力损伤(PIs)是脊髓损伤和疾病(SCI/D)成人常见且昂贵的并发症,全球患病率为32%,澳大利亚的终生风险超过85%。营养是预防和管理PIs的关键因素,支持伤口愈合,免疫功能和整体恢复。本系统综述评估了自2010年以来出版的17份国际临床实践指南(cpg)的质量、范围和方法严严性,其中包括SCI/D成人pi的营养建议。使用AGREE II和AGREE- rex工具,本综述评估了总体指南质量和营养护理过程领域的营养特异性建议。7个cpg被AGREE II评为高质量,3个被AGREE- rex评为高质量。虽然大多数指导方针侧重于营养干预措施,但对评估和监测提供的细节有限。在建议的严谨性和特异性方面发现了相当大的差异。这些发现强调,需要制定高质量的SCI/ d特定指南,提供一致的、循证的、可操作的营养指导,特别是在代表性不足的评估和监测领域,以更好地支持这一弱势群体的PI预防和治疗。
{"title":"Nutrition care in adults with spinal cord injuries and disorders with pressure injuries: A systematic review of clinical practice guidelines","authors":"Yiwen Wang ,&nbsp;Man Ching Lo ,&nbsp;Murray Fisher ,&nbsp;Katherine Desneves ,&nbsp;Amy Nevin ,&nbsp;Priya lyer","doi":"10.1016/j.clnu.2026.106580","DOIUrl":"10.1016/j.clnu.2026.106580","url":null,"abstract":"<div><div>Pressure injuries (PIs) are a common and costly complication in adults with spinal cord injuries and disorders (SCI/D), with a global prevalence of 32 % and a lifetime risk exceeding 85 % in Australia. Nutrition is a key factor in the prevention and management of PIs, supporting wound healing, immune function, and overall recovery. This systematic review evaluated the quality, scope, and methodological rigour of 17 international clinical practice guidelines (CPGs) published since 2010 that included nutrition recommendations for PIs in adults with SCI/D. Using the AGREE II and the AGREE-REX tools, this review assessed overall guideline quality and nutrition-specific recommendations mapped to the Nutrition Care Process domains. Seven CPGs were rated high quality with AGREE II, and three with AGREE-REX. While most guidelines focussed on nutrition interventions, limited detail was provided on assessment and monitoring. Considerable variation was found in the rigour and specificity of recommendations. These findings underscore a need for high-quality, SCI/D-specific guidelines that offer consistent, evidence-based, actionable nutrition guidance, particularly in the under-represented areas of assessment and monitoring, to better support PI prevention and treatment in this vulnerable population.</div></div>","PeriodicalId":10517,"journal":{"name":"Clinical nutrition","volume":"58 ","pages":"Article 106580"},"PeriodicalIF":7.4,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146077060","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effectiveness of probiotic supplementation in managing depressive symptoms and inflammatory status in patients with depression: A systematic review and meta-analysis 补充益生菌对抑郁症患者控制抑郁症状和炎症状态的有效性:一项系统综述和荟萃分析
IF 7.4 2区 医学 Q1 NUTRITION & DIETETICS Pub Date : 2026-03-01 Epub Date: 2026-01-08 DOI: 10.1016/j.clnu.2025.106554
Hajar Nabeel Shakir Shakir , Antonio Javier Alias-Castillo , Daniel Bertini-Pérez , Lola Rueda-Ruzafa , Pablo Roman , Diana Cardona

Background and Aims

Depression is a multifactorial disorder influenced by genetic, biochemical, psychological, and environmental factors, and it significantly impacts quality of life. Probiotics, especially Lactobacillus and Bifidobacterium strains, have been proposed as adjunct therapies due to their capacity to modulate gut microbiota and the gut–brain axis. This systematic review and meta-analysis aimed to evaluate the effectiveness of probiotic supplementation on depressive symptoms and inflammatory status in individuals with depression.

Methods

Articles were identified through searches in databases including PubMed, Scopus, CINAHL, and Zenodo, using terms related to depression, microbiome, and probiotics. The search, conducted between January and February 2025, yielded 780 articles. After removing duplicates and applying eligibility criteria, 13 studies were included in the systematic review and 7 in the meta-analysis.

Results

Probiotic supplementation was significantly associated with improvement in depressive symptoms (p < 0.00001). However, no significant changes were found in inflammatory biomarkers, including interleukin-6 (p = 0.45) and tumor necrosis factor-alpha (p = 0.21).

Conclusions

These results suggest that probiotics may help alleviate depressive symptoms, although their effect on inflammation remains uncertain. Further high-quality studies are necessary to clarify underlying mechanisms and determine the clinical relevance of probiotics as adjunctive therapy in depression..
背景与目的抑郁症是一种受遗传、生化、心理和环境因素影响的多因素疾病,对生活质量有显著影响。益生菌,特别是乳酸菌和双歧杆菌菌株,由于其调节肠道微生物群和肠脑轴的能力,已被提出作为辅助治疗。本系统综述和荟萃分析旨在评估补充益生菌对抑郁症患者抑郁症状和炎症状态的有效性。方法通过检索PubMed、Scopus、CINAHL和Zenodo等数据库,使用与抑郁症、微生物组和益生菌相关的术语对文章进行识别。这项研究于2025年1月至2月进行,共发现780篇文章。在排除重复项并应用资格标准后,13项研究被纳入系统评价,7项研究被纳入荟萃分析。结果补充益生菌与抑郁症状改善显著相关(p < 0.00001)。然而,炎症生物标志物,包括白细胞介素-6 (p = 0.45)和肿瘤坏死因子- α (p = 0.21)未发现显著变化。结论益生菌可能有助于缓解抑郁症状,但其对炎症的影响尚不确定。需要进一步的高质量研究来阐明潜在的机制,并确定益生菌作为抑郁症辅助治疗的临床相关性。
{"title":"Effectiveness of probiotic supplementation in managing depressive symptoms and inflammatory status in patients with depression: A systematic review and meta-analysis","authors":"Hajar Nabeel Shakir Shakir ,&nbsp;Antonio Javier Alias-Castillo ,&nbsp;Daniel Bertini-Pérez ,&nbsp;Lola Rueda-Ruzafa ,&nbsp;Pablo Roman ,&nbsp;Diana Cardona","doi":"10.1016/j.clnu.2025.106554","DOIUrl":"10.1016/j.clnu.2025.106554","url":null,"abstract":"<div><h3>Background and Aims</h3><div>Depression is a multifactorial disorder influenced by genetic, biochemical, psychological, and environmental factors, and it significantly impacts quality of life. Probiotics, especially <em>Lactobacillus</em> and <em>Bifidobacterium</em> strains, have been proposed as adjunct therapies due to their capacity to modulate gut microbiota and the gut–brain axis. This systematic review and meta-analysis aimed to evaluate the effectiveness of probiotic supplementation on depressive symptoms and inflammatory status in individuals with depression.</div></div><div><h3>Methods</h3><div>Articles were identified through searches in databases including PubMed, Scopus, CINAHL, and Zenodo, using terms related to depression, microbiome, and probiotics. The search, conducted between January and February 2025, yielded 780 articles. After removing duplicates and applying eligibility criteria, 13 studies were included in the systematic review and 7 in the meta-analysis.</div></div><div><h3>Results</h3><div>Probiotic supplementation was significantly associated with improvement in depressive symptoms (p &lt; 0.00001). However, no significant changes were found in inflammatory biomarkers, including interleukin-6 (p = 0.45) and tumor necrosis factor-alpha (p = 0.21).</div></div><div><h3>Conclusions</h3><div>These results suggest that probiotics may help alleviate depressive symptoms, although their effect on inflammation remains uncertain. Further high-quality studies are necessary to clarify underlying mechanisms and determine the clinical relevance of probiotics as adjunctive therapy in depression..</div></div>","PeriodicalId":10517,"journal":{"name":"Clinical nutrition","volume":"58 ","pages":"Article 106554"},"PeriodicalIF":7.4,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146049111","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Clinical nutrition
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1